Clinical Trial Update: Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of cisplatin, paclitaxel, and gemcitabine in patients with progressive unresectable regional or metastatic bla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN